RCS - OptiBiotix Health - Launch of GoFigure products on Tmall China

OptiBiotix HealthAnnouncement

01/11/2022 07:16

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221101:nRSA7917Ea&default-theme=true

RNS Number : 7917E  OptiBiotix Health PLC  01 November 2022

OptiBiotix Health plc

("OptiBiotix" or the "Company" or the "Group")

 

Launch of GoFigure products on Tmall China

 

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing
compounds to tackle obesity, cardiovascular disease and diabetes, announces
the opening of an online shop on Tmall.com ("Tmall") for its Go-Figure
products and it has launched GoFigure shakes containing patented weight
management aid SlimBiome® on Tmall China.

 

Tmall is a cross-border marketplace for foreign brands and merchants to sell
directly to Chinese consumers in China. By selling on Tmall, brands and
merchants no longer require a legal entity in China nor hold stock in the
country. OptiBiotix has teamed up with certified Tmall Partner, Agency
InReady, to build, promote and operate its Tmall store as this requires a
specialised and dedicated cross-functional team with a proven track record.

 

GoFigure is OptiBiotix's direct-to-consumer (D2C) range of weight management
products formulated with core ingredient SlimBiome®. The GoFigure range of
products consists of powdered meal replacement & beverage products
(shakes, smoothies, pancake mixes, etc.) and healthy snacking (crisps, puffs,
gummies, etc.). GoFigure is also available as private label range.

 

SlimBiome® is a patented prebiotic weight management aid used by itself or in
formulated products in the health & wellness, sports nutrition and weight
management categories. SlimBiome® is supported by independent human studies
which show it reduces hunger, cravings for sweet and savoury foods and fat
intake, and helps people follow a low calorie diet plan. Consumers who used
SlimBiome® in combination with a calorie restricted diet experience a relief
from feeling hungry and have fewer cravings for food, leading to easier and
more sustainable dieting and lose on average an additional 2kg per month,
improving body composition.

 

René Kamminga, CEO of OptiBiotix Limited, a wholly owned subsidiary of
OptiBiotix Health plc, commented: "I am very pleased with the launch of our
own Tmall store and that we can now focus on getting the GoFigure range direct
to the Chinese consumer. The GoFigure range has been specifically formulated
to support consumers aiming to reduce their weight, help them stick to their
change in diet and improve their gut microbiome at the same time. This
particular range has been adapted specifically to fit the consumer preferences
in China and we are confident that we can build lasting success with our
partner InReady."

 

For further information, please contact:

 

 OptiBiotix Health plc                                  www.optibiotix.com (http://www.optibiotix.com/)
 Stephen O'Hara, Chief Executive  Contact via Walbrook below

 Cenkos Securities plc (Broker)                         Tel: 020 7397 8900
 Callum Davidson / Neil McDonald
 Michael Johnson / Russell Kerr (Sales)

 Walbrook PR Ltd                                        Mob: 07876 741 001
 Anna Dunphy

 

 

This communication is a "Reach" announcement. Reach is a non-regulatory news
service. By using this service an issuer is confirming that the information
contained in this announcement is of a non-regulatory nature. Information
required to be notified under the AIM Rules for Companies, Market Abuse
Regulation or other regulation would be disseminated as an RNS regulatory
announcement and not on RNS Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEAKEFDFKAFFA